Pages that link to "Q37977795"
Jump to navigation
Jump to search
The following pages link to Iron dysregulation in movement disorders (Q37977795):
Displaying 50 items.
- Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management (Q26749945) (← links)
- Sleep disorders: A review of the interface between restless legs syndrome and iron metabolism (Q26781413) (← links)
- Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments (Q27330107) (← links)
- Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study (Q28681958) (← links)
- Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration (Q33627982) (← links)
- Midlife migraine and late-life parkinsonism: AGES-Reykjavik study (Q34269043) (← links)
- The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells (Q34428287) (← links)
- Gene co-expression networks shed light into diseases of brain iron accumulation (Q34506653) (← links)
- Stem cells from wildtype and Friedreich's ataxia mice present similar neuroprotective properties in dorsal root ganglia cells (Q34720833) (← links)
- Behavioral characterization of mouse models of neuroferritinopathy (Q35090866) (← links)
- Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles (Q35664174) (← links)
- Quantitative Susceptibility Mapping in Parkinson's Disease (Q36123740) (← links)
- Transition metals activate TFEB in overexpressing cells (Q36184709) (← links)
- Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders. (Q36275015) (← links)
- Sensory aspects of movement disorders (Q36595746) (← links)
- Striatal development involves a switch in gene expression networks, followed by a myelination event: implications for neuropsychiatric disease (Q36626038) (← links)
- Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy (Q36672116) (← links)
- Metal-induced neurodegeneration in C. elegans (Q36854442) (← links)
- A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers (Q37204665) (← links)
- Descriptive epidemiology of cervical dystonia (Q37293573) (← links)
- Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features (Q37364099) (← links)
- Micronutrients and Risk of Parkinson's Disease: A Systematic Review (Q37429643) (← links)
- Antioxidant gene therapy against neuronal cell death (Q37647941) (← links)
- Mitochondrial metals as a potential therapeutic target in neurodegeneration (Q37686294) (← links)
- Alterations of Hair and Nail Content of Selected Trace Elements in Nonoccupationally Exposed Patients with Chronic Depression from Different Geographical Regions (Q37720991) (← links)
- Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed? (Q38021661) (← links)
- Plasmonics for the study of metal ion-protein interactions. (Q38050985) (← links)
- Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). (Q38065116) (← links)
- The VPS35 gene and Parkinson's disease (Q38093808) (← links)
- The hallmarks of Parkinson's disease (Q38105645) (← links)
- Iron metabolism in the CNS: implications for neurodegenerative diseases (Q38118885) (← links)
- Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population (Q38124286) (← links)
- Review: iron metabolism and the role of iron in neurodegenerative disorders (Q38158631) (← links)
- Role of iron in UPS impairment model of Parkinson's disease (Q38164879) (← links)
- Iron: the hard player in diabetes pathophysiology. (Q38187484) (← links)
- Characterization of biometal profiles in neurological disorders. (Q38197094) (← links)
- Genetic convergence of Parkinson's disease and lysosomal storage disorders (Q38237560) (← links)
- Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease (Q38343049) (← links)
- Iron and Neurodegeneration: Is Ferritinophagy the Link? (Q38607505) (← links)
- Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism. (Q39199926) (← links)
- Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease (Q39411963) (← links)
- Iron overload causes endolysosomal deficits modulated by NAADP-regulated 2-pore channels and RAB7A. (Q39627828) (← links)
- Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. (Q40202363) (← links)
- Migraine is related to an increased risk of Parkinson's disease: A population-based, propensity score-matched, longitudinal follow-up study. (Q40924267) (← links)
- Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports. (Q41460705) (← links)
- Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). (Q41836301) (← links)
- Alterations in the basal ganglia in patients with brain tumours may be due to excessive iron deposition (Q42469086) (← links)
- Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration (Q42518509) (← links)
- MR image mimicking the "eye of the tiger" sign in Wilson's disease. (Q42552491) (← links)
- Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy (Q44649355) (← links)